Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More STEVEN GROSSMAN 7/24/18 STEVEN GROSSMAN 7/24/18 “First, do no harm” Read More Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More Analysis and Commentary STEVEN GROSSMAN 1/5/18 Analysis and Commentary STEVEN GROSSMAN 1/5/18 Ensuring an Effective and Motivated Workforce Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More
Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More
Analysis and Commentary STEVEN GROSSMAN 1/5/18 Analysis and Commentary STEVEN GROSSMAN 1/5/18 Ensuring an Effective and Motivated Workforce Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More
Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More
